Evolent Health (NYSE:EVH) Shares Gap Down – Here’s What Happened

Posted by Geri Gentry on Nov 5th, 2026

Evolent Health, Inc (NYSE:EVH – Get Free Report)’s stock price gapped down before the market opened on Thursday. The stock had previously closed at $4.80, but opened at $4.25. Evolent Health shares last traded at $4.9050, with a volume of 173,665 shares trading hands.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. TD Cowen upped their price target on Evolent Health from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Monday, August 17th. Citigroup raised shares of Evolent Health from a “neutral” rating to a “buy” rating and reduced their target price for the stock from $6.75 to $6.00 in a research report on Monday, August 10th. Weiss Ratings cut shares of Evolent Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, October 16th. Truist Financial lowered their price target on shares of Evolent Health from $7.00 to $6.00 and set a “hold” rating for the company in a report on Wednesday, August 12th. Finally, Canaccord Genuity Group dropped their price target on shares of Evolent Health from $7.00 to $6.00 and set a “buy” rating on the stock in a research note on Monday, August 10th. Eleven equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Evolent Health presently has an average rating of “Moderate Buy” and a consensus price target of $5.96.

Check Out Our Latest Stock Report on EVH

Evolent Health Stock Performance

The company has a market capitalization of $541.44 million, a price-to-earnings ratio of -1.04 and a beta of 1.03. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 2.52. The stock has a 50-day simple moving average of $4.17 and a 200-day simple moving average of $3.88.

Evolent Health (NYSE:EVH – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The technology company reported $0.06 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.06. The business had revenue of $725.37 million during the quarter, compared to the consensus estimate of $727.06 million. Evolent Health had a negative net margin of 24.08% and a negative return on equity of 4.27%. The business’s quarterly revenue was up 51.3% compared to the same quarter last year. During the same quarter last year, the company earned $0.05 earnings per share. On average, analysts anticipate that Evolent Health, Inc will post -0.25 earnings per share for the current year.

Insider Buying and Selling

In other Evolent Health news, President Daniel Mccarthy sold 65,892 shares of the stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $5.00, for a total transaction of $329,460.00. Following the transaction, the president directly owned 655,133 shares in the company, valued at $3,275,665. This represents a 9.14% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.48% of the stock is owned by company insiders.

Hedge Funds Weigh In On Evolent Health

Several large investors have recently modified their holdings of EVH. Vise Technologies Inc. grew its stake in Evolent Health by 76.5% in the third quarter. Vise Technologies Inc. now owns 30,215 shares of the technology company’s stock worth $105,000 after purchasing an additional 13,096 shares in the last quarter. State of Wyoming increased its holdings in Evolent Health by 37.3% in the third quarter. State of Wyoming now owns 113,074 shares of the technology company’s stock valued at $395,000 after buying an additional 30,720 shares during the last quarter. Tempus Wealth Planning LLC increased its holdings in Evolent Health by 20.2% in the third quarter. Tempus Wealth Planning LLC now owns 100,774 shares of the technology company’s stock valued at $352,000 after buying an additional 16,969 shares during the last quarter. Congress Asset Management Co. raised its stake in Evolent Health by 20.3% during the third quarter. Congress Asset Management Co. now owns 275,158 shares of the technology company’s stock valued at $960,000 after buying an additional 46,466 shares in the last quarter. Finally, Sequoia Financial Advisors LLC acquired a new stake in Evolent Health during the second quarter valued at approximately $78,000.

About Evolent Health

(Get Free Report)

Evolent Health, Inc (NYSE: EVH) is a healthcare services and technology company that helps health plans and healthcare providers transition to value-based care. Its platform is designed to support the management of clinical programs, improve patient outcomes and coordinate care while helping customers manage healthcare costs.

The company provides specialty and total-cost-of-care solutions across areas such as cardiology, oncology, musculoskeletal care, radiology and other complex conditions.